ArticleNeural regeneration research2016

Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke.

Emil Zeynalov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.